EGFR and neoplasm: Since tumor size has been reported to be inversely correlated to response to EGFR inhibitors and chemotherapy[43-45] in patients and CBA/lac mice, we next investigated the response to cetuximab in more established tumors in both models by delaying treatment initiation to a tumor size of approximately 70 mm2.